ORIC Pharmaceuticals, Inc. (ORIC)

ORIC Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	56.36	23.38	66.84	226.01	78.45	89.16
Short-Term Investments	260.42	184.8	139.43	10.97	215.15	0
Cash & Cash Equivalents	316.78	208.19	206.27	236.98	293.6	89.16
Cash Growth	67.05%	0.93%	-12.96%	-19.29%	229.30%	109.12%
Other Current Assets	7.31	4.41	4.19	3.54	3.1	0.84
Total Current Assets	324.08	212.6	210.46	240.52	296.7	90
Property, Plant & Equipment	2.8	2.86	3.25	2.41	1.98	2.24
Long-Term Investments	14.69	26.85	21.95	43.39	0	0
Other Long-Term Assets	9.21	9.7	11.52	12.32	0.32	1.85
Total Long-Term Assets	26.7	39.41	36.72	58.12	2.3	4.09
Total Assets	350.79	252.01	247.18	298.64	299	94.09
Accounts Payable	2.99	0.94	1.32	1.89	0.76	0.15
Other Current Liabilities	12.22	19.51	14.07	13.27	8.25	5.2
Total Current Liabilities	15.21	20.46	15.39	15.15	9	5.35
Other Long-Term Liabilities	6.93	7.46	9.44	10.52	0.22	0.77
Total Long-Term Liabilities	6.93	7.46	9.44	10.52	0.22	0.77
Total Liabilities	22.14	27.92	24.83	25.67	9.22	6.12
Retained Earnings	-459.94	-434.93	-334.23	-245.11	-166.39	-92.69
Comprehensive Income	-0.16	0.26	-1.29	-0.1	-0.03	0
Shareholders' Equity	328.65	224.09	222.35	272.98	289.78	-90.08
Net Cash / Debt	316.78	208.19	206.27	236.98	293.6	89.16
Net Cash / Debt Growth	67.05%	0.93%	-12.96%	-19.29%	229.30%	109.12%
Net Cash Per Share	4.70	4.05	5.20	6.24	13.38	46.94
Working Capital	308.87	192.14	195.07	225.37	287.7	84.65
Book Value Per Share	4.88	4.36	5.61	7.19	13.21	-47.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).